STEGLUJAN 100 mg/1

Steglujan 100 mg/1 combines ertugliflozin and sitagliptin for managing type 2 diabetes. This oral medication supports blood sugar control as part of a broader treatment plan.

Steglujan 100 mg/1 is a combination of ertugliflozin and sitagliptin, designed to help manage type 2 diabetes. It works by improving insulin sensitivity and reducing glucose absorption in the kidneys. This medication is often used alongside diet and exercise to control blood sugar levels effectively.

Common effects of Steglujan 100 mg/1 may include urinary tract infections, hypoglycemia, and gastrointestinal discomfort. Individual responses can vary, and not everyone will experience these effects.

Handle Steglujan 100 mg/1 with care, especially if you have a history of kidney or liver issues. Always follow your healthcare provider's instructions and monitor blood sugar levels regularly.

Steglujan 100 mg/1 may interact with other medications, including insulin, diuretics, and certain antibiotics. It's important to discuss all current medications with your healthcare provider to avoid potential interactions.